Personal profile
Biography
Dr Kyle Matchett completed his PhD in October 2010 at Queen’s University Belfast (QUB). His thesis examined the expression of SEPT9 splice variants in ovarian tumours from the SCOTROC trial and array CGH studies with the Institute of Cancer Research, London.
Following his PhD, Dr Matchett was appointed as a Cancer Research UK Postdoctoral Research Fellow at QUB. He discovered that estrogen metabolism is deregulated in BRCA1-deficient breast cells leading to increased production of estrogen metabolites and metabolite-induced DNA damage. Dr Matchett published his work in Cancer Research, and presented it at conferences in Montreal, London and Amsterdam. In recognition of this research, Dr Matchett was awarded the inaugural Professor John Fitzpatrick Prize by the Irish Association for Cancer Research (IACR).
Dr Matchett continued his interest in hormone signalling in breast cancer and moved to take up an EU FP7 Postdoctoral Research Fellow position focused on understanding the role of erythropoietin (EPO) in breast cancer. Based at QUB, his post involved collaboration and extensive travel with partner laboratories in Madrid, Innsbruck, Tel-Aviv, Vienna, Munich and Zurich. During this time, Dr Matchett played a key role in the development of novel EPO receptor antibodies with industrial partners Aldevron (Germany). He also led his own research which resulted in several publications.
In 2015, Dr Matchett was appointed as a Leukaemia and Leukaemia NI Postdoctoral Research Fellow following an increasing interest in haematology. His research focused on developing novel therapeutics for paediatric and adult acute myeloid leukaemia. This work has been recognised both nationally and internationally with a number of grants, invited talks and awards, including a presentation prize at XXXVI World Congress of the International Society of Haematology (2016), Little Princess Trust/Childhood Cancer and Leukaemia Group Project Grant Awards (2017, 2018) and a Novartis Fellowship Prize and Medal (2017).
In addition to his research programme, Dr Matchett completed his PGCHET in 2014 and was awarded a Fellowship of the Higher Education in 2015. He co-led a School-wide study examining postgraduate research student support, which was published in 2018.
Dr Matchett was appointed as a Lecturer at Ulster University in October 2018.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Quercetin activates the SIRT6–Nrf2 axis during oxidative stress, modulating DNA repair and ageing-associated markers
Juan, C. A., Simunic-Briski, N., Matchett, K. & Davison, G., 2 Nov 2025, (Published online) p. 1-52, 52 p.Research output: Working paper › Preprint
File44 Downloads (Pure) -
Theranostics for Neuroblastoma: Making Molecular Radiotherapy Work Better
Gawne, P. J., Bryant, H. E., DuBois, S. G., George, S. L., Gray, J., Knox, L., Matchett, K. B., Peet, C., Vallis, K. A., Wallace, H. J., Wan, S. & Gaze, M. N., 1 Apr 2025, In: Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 66, 4, p. 490-496 7 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile4 Link opens in a new tab Citations (Scopus)70 Downloads (Pure) -
Developing epigenetic synergistic drug combinations with albendazole in paediatric acute myeloid leukaemia
Carlin, S., Bond, J., McKenna, D. J., Lynch, S. & Matchett, K., 27 Feb 2024, (Published online).Research output: Contribution to conference › Poster › peer-review
Open Access -
Exercise and Nutrition: Metabolic Partners in Epigenetic Regulation
Juan, C. A., Matchett, K. & Davison, G., 28 May 2024, Epigenetics and Human Health. Vaschetto, L. (ed.). Springer Cham, Vol. 12. p. 183-216 34 p. (Epigenetics and Human Health; vol. 12).Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
1 Link opens in a new tab Citation (Scopus) -
High-content Drug Screen Identification of Albendazole as a Novel Compound With Efficacy in Paediatric Acute Myeloid Leukaemia in Vitro and in Vivo
Lynch, S., Wilson, R., Ní Chonghaile, T., Thompson, A., Mills, K., Levine, R. & Matchett, K., 28 Feb 2024, (Published online).Research output: Contribution to conference › Paper › peer-review
Open Access
Prizes
-
Collaborative Award for Teaching Excellence (CATE)
McClean, P. (Recipient), Kelly, C. (Recipient), Atkinson, S. (Recipient), Bjourson, T. (Recipient), Duddy, W. (Recipient), Duguez, S. M. (Recipient), Gibson, D. (Recipient), Matchett, K. (Recipient), McDowell, A. (Recipient), Mc Gilligan, V. (Recipient), Murray, E. (Recipient), Shukla, P. (Recipient), Rai, T. S. (Recipient), Watterson, S. (Recipient) & Zhang, S.-D. (Recipient), 3 Oct 2024
Prize: Honorary award
-
Distinguished Collaborative Education Excellence Fellowship
McClean, P. (Recipient), Kelly, C. (Recipient), Gibson, D. (Recipient), Mc Gilligan, V. (Recipient), Murray, E. (Recipient), Atkinson, S. (Recipient), Watterson, S. (Recipient), McDowell, A. (Recipient), Duguez, S. M. (Recipient), Duddy, W. (Recipient), Shukla, P. (Recipient), Matchett, K. (Recipient), Rai, T. S. (Recipient) & Zhang, S.-D. (Recipient), 7 Jun 2023
Prize: Honorary award
-
-
UKRI (External organisation)
Matchett, K. (Member)
13 Nov 2020Activity: Membership › Membership of committee
-
Profiles
-
BBSRC NI Landscape partnership in AI for Biosciences
McNulty, H. (PI), Hughes, C. (CoI), Zheng, H. (CoI), Matchett, K. (CoI) & Black, M. (CoI)
Biotechnology & Biological Sciences Research Council
1/07/25 → 30/06/33
Project: Research
-
Chronic Lymphocytic Leukaemia (CLL) - Follow on project from AICRI 433942
Matchett, K. (PI)
15/04/25 → 14/04/30
Project: Research
-
AICRIstart: A Foundation Stone for the All-Island Cancer Research Institute (AICRI): Building Critical Mass in Precision Cancer Medicine - Strand III
Matchett, K. (PI), Gault, V. (CoI) & McDowell, A. (CoI)
1/09/22 → 31/08/26
Project: Research
-
Identifying molecular vulnerabilities in childhood acute myeloid leukaemia and developing more effective, kinder therapies
Matchett, K. (PI)
1/10/19 → 30/09/29
Project: Research
-
Personalised Medicine Centre Multi-Omics Lab (PMC-MOL) - Wolfson Equipment Bid
Kelly, C. (PI), Gibson, D. (CoI), Murray, E. (CoI), Matchett, K. (CoI), McClean, P. (CoI), Shukla, P. (CoI), Zhang, S.-D. (CoI), Duguez, S. M. (CoI), Watterson, S. (CoI), Rai, T. S. (CoI), McGilligan, V. (CoI) & Duddy, W. (CoI)
1/06/25 → 31/12/25
Project: Research